AIM ImmunoTech Inc

ASE:AIM  
2.00
+0.07 (+3.63%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)99.61M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.04 Million
Adjusted EPS-$0.07
See more estimates
10-Day MA$2.04
50-Day MA$2.19
200-Day MA$2.17
See more pivots

AIM ImmunoTech Inc Stock, ASE:AIM

2117 South West Highway 484, 2117 SW Highway 484, Ocala, Florida 34473
United States of America
Phone: +1.352.448.7797
Number of Employees: 23

Description

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.